AstraZeneca Seeks To Block Dr Reddy’s US Brilinta Rival

 
• By Penelope MacRae
  
AstraZeneca
AstraZeneca has flagged up Dr Reddy’s Paragraph IV ANDA • Source: Shutterstock

More from Generics

More from Products